Nanomedicine in the Treatment and Management of Alzheimer's Disease

個数:
  • 予約

Nanomedicine in the Treatment and Management of Alzheimer's Disease

  • 現在予約受付中です。出版後の入荷・発送となります。
    重要:表示されている発売日は予定となり、発売が延期、中止、生産限定品で商品確保ができないなどの理由により、ご注文をお取消しさせていただく場合がございます。予めご了承ください。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 368 p.
  • 言語 ENG
  • 商品コード 9781032895512

Full Description

This book aims to discuss the various drug delivery approaches of neuroprotective medicines via nanoparticles, such as enzymes, monoclonal antibodies, neurotrophic factors, pharmaceutical drugs, and nucleic acid-based medication, to manage Alzheimer's disease.

Nanomedicine in the Treatment and Management of Alzheimer's Disease investigates drug administration approaches, either separately or in combination, to improve neuroprotection in Alzheimer's disease. The book examines various novel therapeutic applications of nanomaterials in drug delivery for the central nervous system in Alzheimer's disease treatment. The book explores the role of nanoparticles in crossing the blood-brain barrier and blood-CSF barrier in the treatment and management of Alzheimer's disease. The authors also explain the nanoparticle-based delivery of therapeutic molecules including phytochemicals, peptides, siRNA, enzymes, and monoclonal antibodies in the treatment of Alzheimer's disease. Finally, the book also discusses the various challenges and future perspectives of nanomedicine in the management of Alzheimer's disease.

The book will help in bridging the gap of knowledge in neurosciences, neurotherapeutics, nanotechnology, and nanomedicine domains. The book chapter may be useful to educators, researchers, legislators, and medical professionals including pharmacologists, biochemists, corporate pharma R&D researchers, neurologists, and scientists involved in neurodegenerative diseases and nanomedicine.

Contents

Chapter 1 Overview of Neuropathology of Alzheimer's Disease Chapter 2 Current Therapeutic Targets and Approaches in the Treatment of Alzheimer's Disease Chapter 3 Pharmacological approaches to alleviate neuroinflammation in Alzheimer's disease Chapter 4 Nanotechnological advances in the delivery of CNS therapeutics Chapter 5 Nanomedicine: A Promising Way to Manage Alzheimer's Disease Chapter 6 Gold nanoparticles-based drug delivery for Treatment and Management of Alzheimer's Disease Chapter 7 Lipid-based nanocarrier in the management of Alzheimer's Disease Chapter 8 Chitosan-Based Nanoparticles in the Treatment of Alzheimer's Disease Chapter 9 Polymeric Nanoparticles-Based Therapeutic Strategies for Alzheimer's Disease Chapter 10 Carbon dots: Blood-brain barrier penetrating drug nanocarrier in the treatment of Alzheimer's disease Chapter 11 Nanoparticles-based Immunotherapeutic Strategies for the Treatment of Alzheimer's Disease Chapter 12 Nanoparticles-Based Sirna Delivery in the Treatment and Management of Alzheimer's Disease Chapter 13 Engineering Nanoparticles in Drug Delivery for Alzheimer's Disease Treatment Chapter 14 Recent Progress of Nanomedicine in The Treatment of Alzheimer's Disease Chapter 15 Challenges and Opportunities of Nanomedicines in Clinical Translation

最近チェックした商品